Inotropes and Vasopressors for FRCEM

Inotropes and vasopressors are tested frequently in MRCEM SBA, FRCEM SBA and FRCEM OSCE because they sit at the junction of pharmacology, physiology and resuscitation. Examiners usually do not ask for drug classification alone. They present a shocked patient and expect you to identify the haemodynamic problem, treat the cause, and choose the safest vasoactive strategy. In UK practice, this means understanding when noradrenaline is first-line, when adrenaline is the right answer, when dobutamine may help, and when vasoactive drugs are not the primary treatment at all.

Why Inotropes and Vasopressors Matter for FRCEM

Emergency clinicians use vasoactive drugs in patients with septic shock, cardiogenic shock, anaphylaxis, peri-intubation hypotension and refractory circulatory failure. These drugs can be life-saving, but they can also worsen shock if the underlying problem is misunderstood.

The key ED principle is simple:

• treat the cause of shock, not just the blood pressure number
• decide whether the main problem is low preload, low systemic vascular resistance, low cardiac output, or mechanical obstruction
• choose a vasoactive drug only when it matches the haemodynamic problem

Common exam traps include:

• choosing adrenaline instead of noradrenaline as first-line treatment in septic shock
• forgetting that IM adrenaline is first-line in anaphylaxis
• using dobutamine alone in profound hypotension
• giving vasopressors before correcting major hypovolaemia or obstruction
• assuming vasopressin has inotropic effects
• misinterpreting a raised lactate after adrenaline as proof of worsening shock

Key Definitions

• Inotrope: a drug that increases myocardial contractility.
• Vasopressor: a drug that increases vascular tone and systemic vascular resistance, thereby increasing arterial pressure.
• Inodilator: a drug that increases contractility while reducing afterload through vasodilation.

These categories overlap. Many clinically important drugs have mixed effects.

Essential Pathophysiology

For bedside haemodynamic reasoning, mean arterial pressure is broadly related to cardiac output and systemic vascular resistance. This is a useful simplification for exams, but perfusion is not defined by blood pressure alone. Always assess end-organ perfusion as well.

Low blood pressure in shock usually reflects one or more of the following:

• low preload or inadequate circulating volume
• low SVR
• low cardiac output
• mechanical obstruction to filling or output

Typical patterns:

A MAP target of at least 65 mmHg is a common initial target in septic and other vasodilatory shock, but it is not universal. Targets should be individualised in chronic severe hypertension, neurocritical care, aortic pathology and selected trauma patients.

Receptor effects worth knowing:

Clinical Presentation

Patients needing inotropes or vasopressors usually present with shock or impending shock. The examination stem may include:

• hypotension or falling blood pressure
• tachycardia or relative bradycardia
• altered mental state
• cold or mottled peripheries, or warm vasodilated peripheries
• oliguria
• rising lactate or metabolic acidosis
• pulmonary oedema in cardiogenic shock
• wheeze, stridor, urticaria or angioedema in anaphylaxis
• raised JVP, unilateral absent breath sounds, or tamponade features in obstructive shock

Exam questions often provide enough information to identify the phenotype:

• warm peripheries, sepsis, low MAP after fluids: think vasodilatory shock and noradrenaline
• pulmonary oedema, cool peripheries, low BP, ACS: think cardiogenic shock
• rash, wheeze, hypotension after allergen exposure: think anaphylaxis and IM adrenaline
• major haemorrhage or severe dehydration: think volume replacement first
• tamponade, tension pneumothorax or massive PE: think obstruction and definitive intervention

Red Flags and High-Risk Features

• persistent hypotension despite initial resuscitation
• MAP below target with signs of hypoperfusion
• worsening mental state
• oliguria or anuria
• rising lactate with clinical deterioration
• need for escalating vasopressor doses or more than one vasoactive agent
• arrhythmia complicating shock
• pulmonary oedema with hypotension
• peri-arrest physiology
• suspected obstructive or haemorrhagic shock

These patients need early senior involvement and usually critical care input.

Differential Diagnosis

Before selecting a vasoactive drug, decide which shock state is present.

Initial ED Assessment

Use an ABCDE approach.

Immediate priorities

• recognise shock early
• call for senior help early in unstable patients
• give high-flow oxygen if hypoxic or critically unwell
• obtain IV or IO access
• start monitoring: ECG, pulse oximetry, blood pressure
• consider arterial line early if ongoing vasoactive support is likely
• identify and treat immediately reversible causes

Focused haemodynamic assessment

• Is the patient underfilled?
• Is the patient vasodilated?
• Is the patient in pump failure?
• Is there a mechanical obstruction?

Useful bedside markers of perfusion

• mental state
• capillary refill and skin perfusion
• urine output in catheterised shocked patients
• lactate trend
• acid-base status
• bedside echo where available and operator competent

Investigations

Investigations should support diagnosis, identify the cause of shock, and guide escalation.

• venous or arterial blood gas including lactate
• FBC, U&E, creatinine, LFTs, CRP
• blood cultures if sepsis suspected
• group and save or crossmatch if bleeding possible
• troponin if ACS or cardiogenic shock suspected
• coagulation profile
• 12-lead ECG
• chest radiograph where appropriate
• point-of-care ultrasound or echocardiography if available
• CT imaging if stable enough and diagnosis requires it, for example PE or source identification

Lactate is useful but must be interpreted in context. It reflects illness severity and perfusion stress, not simply tissue hypoxia. Adrenaline and other beta-agonists can increase lactate through beta-mediated glycolysis.

Management in the Emergency Department

Step 1: Treat the cause of shock

• sepsis: antibiotics, source control, fluids, reassessment
• anaphylaxis: IM adrenaline, airway and breathing management, fluids
• haemorrhage: control bleeding, activate major haemorrhage protocol, blood products
• tamponade: urgent drainage
• tension pneumothorax: immediate decompression
• massive PE: urgent senior-led reperfusion strategy
• ACS-related cardiogenic shock: urgent cardiology input and reperfusion pathway

Step 2: Optimise preload where appropriate

Do not use vasopressors as a substitute for volume replacement in major hypovolaemia.

• give prompt IV crystalloid in sepsis with hypotension or hypoperfusion, then reassess dynamically
• use blood product-based resuscitation in haemorrhagic shock
• avoid fluid overload in cardiogenic shock or patients at high risk of pulmonary oedema

Step 3: Choose the right vasoactive strategy

Step 4: Start vasoactive support safely

In UK ED practice, central venous access is preferred for ongoing vasopressor infusion. However, vasopressors should not be dangerously delayed while waiting for a central line.

Peripheral vasopressor use is acceptable as a short-term bridge if local policy supports it and safety criteria are met:

• large-bore cannula in a proximal large vein
• dedicated line
• pump-controlled infusion
• approved local concentration and protocol
• frequent documented site checks
• clear plan for early central access if ongoing need

If extravasation occurs:

• stop the infusion immediately
• leave the cannula in place initially if local protocol advises aspiration
• follow local extravasation guidance
• seek urgent senior help
• use antidote treatment such as phentolamine if available and locally recommended

Step 5: Monitor and reassess continuously

• continuous ECG
• continuous blood pressure monitoring; arterial line early if ongoing titration
• pulse oximetry
• regular assessment of mental state and peripheral perfusion
• urine output monitoring in significant shock, usually via catheter
• serial blood gas and lactate where relevant
• watch for arrhythmia, ischaemia and extravasation

Agent-by-agent high-yield profiles

Noradrenaline

Noradrenaline is the key FRCEM vasopressor. It is the standard first-line vasopressor in septic shock with persistent hypotension after initial fluid resuscitation.

• Main effect: predominantly alpha-mediated vasoconstriction, increasing SVR and MAP
• Typical uses: septic shock, vasodilatory shock, hypotensive cardiogenic shock to support perfusion pressure
• Advantages: predictable first-line vasopressor in modern UK practice
• Adverse effects: peripheral and mesenteric ischaemia, tachyarrhythmia, myocardial ischaemia, extravasation injury
• Exam pearl: septic shock after fluids equals noradrenaline first-line

Adrenaline

Adrenaline has mixed alpha and beta effects. It increases heart rate, contractility and vascular tone, and also causes bronchodilation.

• Main effect: mixed inotrope and vasopressor
• Typical uses: anaphylaxis, cardiac arrest, selected refractory or mixed shock states
• First-line in anaphylaxis: IM adrenaline, repeated if needed according to Resuscitation Council UK guidance
• Not first-line for routine septic shock
• Adverse effects: tachycardia, arrhythmia, myocardial ischaemia, tremor, anxiety, lactate rise
• Exam pearl: adrenaline is the right answer in anaphylaxis, not in standard septic shock after fluids

Dobutamine

Dobutamine is the main inotrope-dominant drug tested in cardiogenic shock.

• Main effect: increases contractility and cardiac output; also causes vasodilation
• Typical uses: low-output states, especially cardiogenic shock when blood pressure is adequate or has been supported
• Major caution: may worsen hypotension if used alone in profound shock
• Adverse effects: tachyarrhythmia, hypotension, myocardial ischaemia
• Exam pearl: dobutamine improves output, not necessarily blood pressure

Vasopressin

Vasopressin is a non-catecholamine vasoconstrictor acting mainly via V1 receptors.

• Main effect: increases vascular tone without direct inotropic or chronotropic effect
• Typical uses: adjunct in refractory vasodilatory shock under senior or critical care guidance
• Not a routine first-line replacement for noradrenaline
• Adverse effects: ischaemia, hyponatraemia in some contexts, reduced splanchnic perfusion
• Exam pearl: vasopressin is a vasopressor, not an inotrope

Dopamine

Dopamine is now lower yield clinically but remains a common exam distractor.

• Main effect: dose-dependent and less predictable than other agents
• Current role: limited in modern UK emergency practice
• Major caution: more arrhythmogenic than noradrenaline
• Exam pearl: dopamine is not routine first-line vasopressor therapy in septic shock

Phenylephrine

Phenylephrine is a pure alpha agonist.

• Main effect: increases SVR without direct inotropy
• Potential problem: may reduce cardiac output and cause reflex bradycardia
• Role: limited and context-specific; not a routine first-line ED vasopressor for shock
• Exam pearl: often included as a distractor when the stem really requires noradrenaline or treatment of the cause

Metaraminol

Metaraminol is worth recognising in UK practice as a short-term temporising vasopressor.

• Main use: peri-intubation hypotension or short bridge while preparing definitive vasopressor support
• Role: temporary measure, not standard definitive treatment for septic shock
• Exam pearl: if the question asks for the standard ongoing vasopressor in septic shock, the answer remains noradrenaline

Milrinone

Milrinone is an inodilator.

• Main effect: increases contractility and reduces afterload
• Role: specialist use rather than routine ED first-line therapy
• Major caution: can worsen hypotension
• Exam pearl: know the concept of an inodilator, but it is lower yield than noradrenaline, adrenaline and dobutamine

Shock-specific ED management

Septic shock

• give prompt IV crystalloid for hypotension or hypoperfusion, with dynamic reassessment
• start broad-spectrum antibiotics early
• seek source control
• if hypotension persists after initial fluid resuscitation, start noradrenaline
• target perfusion, not blood pressure alone
• consider vasopressin as adjunct in refractory vasodilatory shock under critical care guidance

Anaphylaxis

• IM adrenaline is first-line
• repeat if needed according to response and guideline timing
• manage airway and breathing aggressively
• give IV fluids
• steroids and antihistamines are not first-line treatments for life-threatening anaphylaxis
• IV adrenaline is reserved for refractory shock, peri-arrest or arrest, and should be given only by experienced clinicians with continuous monitoring

Cardiogenic shock

• treat the cause urgently: ACS, arrhythmia, mechanical complication, valvular catastrophe
• if hypotensive, noradrenaline is commonly used to maintain coronary and cerebral perfusion pressure
• if low output persists and BP is adequate or supported, dobutamine may be added
• avoid assuming fluid boluses will help; assess carefully
• early cardiology and critical care involvement is essential

Hypovolaemic shock

• replace volume and treat the cause
• in haemorrhage, prioritise bleeding control and blood products
• vasopressors do not correct the underlying problem
• they may be used only as a temporary bridge in extreme peri-arrest situations after at least partial volume replacement and senior decision-making

Obstructive shock

• identify the obstruction quickly
• decompress tension pneumothorax
• drain tamponade
• consider urgent reperfusion strategy for massive PE
• vasoactive drugs are at best a bridge while definitive treatment is arranged

Neurogenic shock

• consider after spinal cord injury
• assess volume status
• vasopressor support is often needed because the problem is loss of vascular tone
• treat clinically significant bradycardia according to bradycardia guidance
• do not assume atropine alone treats the shock state

Peri-intubation hypotension

This is a practical ED scenario and a common viva topic.

• anticipate hypotension in sepsis, trauma, severe acidosis and cardiogenic shock
• optimise preload where appropriate before induction
• prepare push-dose or short-acting temporising support only if used within local governance
• metaraminol may be used in some UK departments as a temporary bridge
• if ongoing vasopressor support is needed after intubation, establish a definitive infusion, usually noradrenaline in vasodilatory shock

Disposition, Referral and Follow-Up

Any patient needing ongoing inotrope or vasopressor support requires senior review and usually critical care-level care.

• refer early to ICU or anaesthetics for ongoing vasoactive support
• involve cardiology early in cardiogenic shock or ACS
• involve relevant specialty teams for source control, haemorrhage control or obstructive causes
• patients with transient peri-intubation or procedural hypotension still need close observation and reassessment

Disposition is usually:

• ICU for ongoing vasopressor or inotrope infusion
• HDU in selected stable cases depending on local capability
• specialist ward only if vasoactive support is no longer required and the patient is clearly improving

Special Groups

Paediatrics

• drug choice, concentration and route differ from adult practice
• paediatric shock management should follow local paediatric and APLS-based guidance
• adrenaline remains first-line in paediatric anaphylaxis
• seek senior paediatric and anaesthetic support early

Pregnancy

• treat maternal shock aggressively because maternal resuscitation is fetal resuscitation
• adrenaline is still first-line in anaphylaxis during pregnancy
• consider left lateral tilt or uterine displacement in later pregnancy
• involve obstetrics early

Older adults

• may have limited physiological reserve and atypical presentation
• fluid resuscitation requires careful reassessment, especially with heart failure or renal impairment
• vasopressor need may arise earlier because fluid tolerance is lower

Immunosuppressed patients

• sepsis may present subtly but deteriorate rapidly
• early antibiotics, source identification and escalation are essential
• do not delay vasopressors in persistent hypotension after initial resuscitation

Patients on beta-blockers

• tachycardic response may be blunted
• anaphylaxis may be more severe and less responsive to standard treatment
• follow anaphylaxis guidance and seek senior help early in refractory cases

Common Pitfalls

• treating the blood pressure number without identifying the shock phenotype
• starting vasopressors before correcting major hypovolaemia
• missing obstructive shock and delaying definitive treatment
• choosing adrenaline instead of noradrenaline in standard septic shock
• forgetting IM adrenaline is first-line in anaphylaxis
• using dobutamine alone in a profoundly hypotensive patient
• assuming all inotropes increase blood pressure
• assuming vasopressin improves contractility
• failing to monitor for extravasation during peripheral vasopressor use
• overinterpreting lactate without considering drug effects and the wider clinical picture

FRCEM and MRCEM Exam Tips

• If the stem says sepsis, fluids already given, MAP still low, and poor perfusion persists, the answer is usually noradrenaline.
• If the stem says anaphylaxis, the answer is IM adrenaline unless the patient is peri-arrest or refractory under expert care.
• If the stem says cardiogenic shock with severe hypotension, think perfusion pressure first. Noradrenaline is often used initially; dobutamine may be added later if low output persists.
• If the stem says haemorrhage or dehydration, the answer is volume replacement and treatment of the cause, not a vasopressor.
• If the stem says tamponade, tension pneumothorax or massive PE, the answer is definitive treatment of the obstruction.
• Dopamine is usually a distractor in modern UK septic shock questions.
• Phenylephrine is lower yield and not routine first-line ED vasopressor therapy.
• Vasopressin is an adjunct vasopressor in refractory vasodilatory shock, not an inotrope.
• Adrenaline can raise lactate. Do not assume this always means worsening shock.
• Any patient on ongoing vasoactive infusion usually needs ICU-level care.

How This Appears in SBA Questions

Typical question stems

• A patient with septic shock remains hypotensive after IV fluids and antibiotics. Which vasoactive drug should be started?
• A patient with ACS has pulmonary oedema, cool peripheries and hypotension. Which drug is most appropriate to support circulation initially?
• A patient develops wheeze, urticaria and hypotension after antibiotic administration. What is the first-line treatment?
• A trauma patient with hypotension and distended neck veins has absent breath sounds on one side. What is the next best step?
• A patient on adrenaline infusion has a rising lactate. What is the best interpretation?

Key discriminator clues

Common wrong answer traps

• Adrenaline in septic shock: wrong unless the stem suggests refractory or mixed shock and senior escalation.
• Dobutamine in profound hypotension: wrong as sole initial agent because it may worsen BP.
• Dopamine as routine first-line: outdated and usually wrong.
• Phenylephrine for septic shock: usually wrong in ED practice.
• Vasopressors in haemorrhage: wrong if blood and bleeding control have not been prioritised.

Key Takeaways

• Choose vasoactive drugs by shock phenotype, not by memorised classification alone.
• Noradrenaline is the first-line vasopressor in septic shock with persistent hypotension after initial fluid resuscitation.
• Adrenaline is first-line in anaphylaxis, usually by the IM route.
• Dobutamine is an inotrope that may improve cardiac output but can worsen hypotension.
• Vasopressin increases vascular tone but has no direct inotropic effect.
• Dopamine is not routine first-line vasopressor therapy in modern UK septic shock practice.
• Hypovolaemic and obstructive shock require correction of the underlying problem before vasoactive drugs.
• Peripheral noradrenaline can be used as a short-term bridge under local protocol, but ongoing support usually requires central access and ICU involvement.
• Lactate must be interpreted in context; adrenaline can increase lactate without necessarily indicating worsening perfusion.
• Any patient needing ongoing inotrope or vasopressor support usually requires critical care-level management.

Further Reading

• NICE guideline NG51: Sepsis: recognition, diagnosis and early management
• Resuscitation Council UK: Emergency treatment of anaphylaxis guidelines
• RCEM guidance and learning resources on sepsis, shock and emergency airway management
• British National Formulary for prescribing information and cautions
• Intensive Care Society guidance relevant to vasopressor administration and haemodynamic support
• ALS and APLS course materials for bradycardia, anaphylaxis and peri-arrest care

Related on EM Final Exams

• Top 50 Emergency Drugs for FRCEM
• RSI Drugs Explained for FRCEM Exams
• Sepsis NICE NG51 What You Actually Need to Know
• Major Trauma Management ATLS vs NICE vs RCEM

Authoritative Sources

• BNF (British National Formulary)
• RCEM Learning resources

Ready to build your plan? EMF Premium gives you all 40,000 questions and 20 mocks for £59 — one payment, six months' access.